Cervical precancer tissue marker study
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial looks at proteins in cervical biopsy tissue to better understand how precancerous lesions develop and to predict their outcome. It may help find better ways to diagnose and monitor these changes in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a cervical precancer (CIN or SIL).
- You have had a cervical biopsy or a procedure that removed a sample of cervical tissue.
- Your tissue sample is stored in the hospital's pathology lab.
- You agree to let the research team use your stored tissue sample for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new tool called PreCursor-M+® to see how well it helps doctors manage CIN2, a moderate cervical cell change. It’s for people who have already been diagnosed with CIN2 and know their HPV test results.
This study is testing whether certain markers in your blood or tissue can help find lung cancer early. It is for people who have lung cancer that can be removed by surgery and haven't had treatment yet.
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
This study uses a special blood test to identify immune markers that may help detect early cervical changes caused by HPV16 or HPV18. If successful, this could offer a simpler way to find cervical problems earlier.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
Hear when a new Cervix Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.